These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 1370684)

  • 1. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.
    Herman A; Labrecque N; Thibodeau J; Marrack P; Kappler JW; Sekaly RP
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9954-8. PubMed ID: 1946464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
    Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
    Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of staphylococcal enterotoxin A requires interactions with both the alpha and beta chains of HLA-DR.
    Dowd JE; Karr RW; Karp DR
    Mol Immunol; 1996 Nov; 33(16):1267-74. PubMed ID: 9129163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal toxins bind to different sites on HLA-DR.
    Chintagumpala MM; Mollick JA; Rich RR
    J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II.
    Leder L; Llera A; Lavoie PM; Lebedeva MI; Li H; Sékaly RP; Bohach GA; Gahr PJ; Schlievert PM; Karjalainen K; Mariuzza RA
    J Exp Med; 1998 Mar; 187(6):823-33. PubMed ID: 9500785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
    Stevens KR; Van M; Lamphear JG; Rich RR
    J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
    Hudson KR; Tiedemann RE; Urban RG; Lowe SC; Strominger JL; Fraser JD
    J Exp Med; 1995 Sep; 182(3):711-20. PubMed ID: 7650479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR V beta-specific interactions.
    Lamphear JG; Mollick JA; Reda KB; Rich RR
    J Immunol; 1996 Mar; 156(6):2178-85. PubMed ID: 8690907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
    J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
    Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
    J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
    Dowd JE; Jenkins RN; Karp DR
    J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative relationship between MHC class II-superantigen complexes and the balance of T cell activation versus death.
    Lavoie PM; McGrath H; Shoukry NH; Cazenave PA; Sékaly RP; Thibodeau J
    J Immunol; 2001 Jun; 166(12):7229-37. PubMed ID: 11390471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
    Labrecque N; Thibodeau J; Mourad W; Sékaly RP
    J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding.
    Thibodeau J; Cloutier I; Lavoie PM; Labrecque N; Mourad W; Jardetzky T; Sékaly RP
    Science; 1994 Dec; 266(5192):1874-8. PubMed ID: 7997881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
    Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
    J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.